Modified erythropoietin polypeptides and uses thereof for treatment
US8252743B2 · kind B2 · utility
12Cited by
62References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 2007 |
| Grant date | Aug 28, 2012 |
| Priority date | — |
| Expiry date | Mar 13, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modified erythropoietin (EPO) polypeptides and other modified therapeutic polypeptides are provided. The EPO polypeptides and other therapeutic polypeptides are modified to exhibit physical properties and activities that differ from the unmodified EPO polypeptides and other unmodified therapeutic polypeptides, respectively. Nucleic acid molecules encoding these polypeptides also are provided. Also provided are methods of treatment and diagnosis using the polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.